WhatsApp Image 2026-05-24 at 12.51.10 DR.jpeg
WhatsApp Image 2026-05-24 at 12.51.10 DR.jpeg

TIRZEPATIDE 10mg

$119.00

Dual agonist of GIP and GLP-1 receptors for advanced metabolic research.

Dual mechanism that synchronizes central satiety, gastric emptying, and insulin sensitivity.

10 mg vial, ideal for intermediate-duration research protocols.

High-purity compound, intended exclusively for scientific research purposes.

Dual agonist of GIP and GLP-1 receptors for advanced metabolic research.

Dual mechanism that synchronizes central satiety, gastric emptying, and insulin sensitivity.

10 mg vial, ideal for intermediate-duration research protocols.

High-purity compound, intended exclusively for scientific research purposes.

Product Details

Tirzepatide is a focus for researchers studying incretin biology. As a dual agonist, it engages both the GIP and GLP-1 receptors, providing a model for examining how combined incretin signaling differs from selective GLP-1 activation. Studies use Tirzepatide to investigate receptor-binding dynamics and the synergistic effects of dual engagement on pancreatic and metabolic signaling in cellular models.

01

02

Dual Incretin Receptor Engagement

Glucose Homeostasis & Insulin Response

In metabolic research, Tirzepatide is investigated for its influence on glucose-dependent insulin secretion. Researchers study how dual incretin signaling modulates the insulinotropic response in pancreatic beta-cell models, examining the interplay between the two receptor pathways in regulating glucose handling.

Recent studies have utilized Tirzepatide to investigate effects on lipid metabolism. By examining how combined GIP and GLP-1 engagement influences adipose signaling and substrate partitioning, researchers explore the peptide’s role in energy-balance and body-composition research within preclinical models.

03

Adipose Metabolism & Energy Partitioning